Posted in | News

Cabot Corp. Signs Joint Venture to Establish Fumed Silica Facility in China

Cabot Corporation announced today that its subsidiary, Cabot (China) Ltd., has signed a joint venture agreement with the China National Bluestar Group to build a facility for the manufacture of fumed silica in China.

The agreement was signed in Beijing on May 16, 2008 and represents an expansion of the relationship between the two companies, which began with the construction of China's first state of the art fumed silica manufacturing facility in Jiangxi province in 2004.

To expand the relationship, Cabot Bluestar Chemical (Tianjin) Co., Ltd, the new joint venture company, will invest approximately US $40 million to build Cabot's next world class fumed silica facility, with a manufacturing capacity of approximately 7000 metric tons per year. The plant will be located in Tianjin, China and will be commissioned in early 2010.

Patrick Prevost, Cabot's President and CEO said, "China is an increasingly important part of Cabot's global business. Our business and manufacturing experience in China over the past 20 years has been extremely positive. The Bluestar Group has been a highly valued partner in our Jiangxi silica plant. Our new joint project in Tianjin will allow us to broaden this partnership. The expansion will build on the success of our other manufacturing facilities in Tianjin's rapidly developing Binhai New Area. Once commissioned, our new Tianjin silica plant will be a long-term, reliable source of high quality materials for Bluestar and other customers in and outside China."

Ren Jianxin, founder of China National Bluestar Group and President of its parent company ChemChina, said, "We are pleased with the expansion and deepening of our relationship with Cabot. This new facility, which will be built in close cooperation between Cabot and Bluestar, will be state-of-the- art for fumed silica production and will be a great help to the growth of the Chinese silicone industry."

Posted May 16th,2008

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.